Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$209.01 - $232.56 $1.18 Million - $1.31 Million
5,641 Added 10.94%
57,209 $12.5 Million
Q4 2023

Feb 08, 2024

BUY
$197.69 - $227.29 $1.55 Million - $1.78 Million
7,842 Added 17.93%
51,568 $11.7 Million
Q3 2023

Oct 24, 2023

BUY
$201.05 - $221.7 $3.24 Million - $3.57 Million
16,094 Added 58.24%
43,726 $8.79 Million
Q2 2023

Jul 31, 2023

SELL
$211.93 - $241.33 $134,151 - $152,761
-633 Reduced 2.24%
27,632 $6.67 Million
Q1 2023

May 08, 2023

BUY
$213.32 - $257.83 $208,626 - $252,157
978 Added 3.58%
28,265 $6.48 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $8,148 - $9,958
-40 Reduced 0.15%
27,287 $6.42 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $231,435 - $296,274
-1,130 Reduced 3.97%
27,327 $5.6 Million
Q2 2022

Nov 14, 2022

BUY
$213.86 - $277.87 $579,988 - $753,583
2,712 Added 10.53%
28,457 $6.67 Million
Q2 2022

Sep 13, 2022

BUY
$213.86 - $277.87 $222,414 - $288,984
1,040 Added 3.27%
32,891 $7.71 Million
Q2 2022

Aug 02, 2022

BUY
$213.86 - $277.87 $362,492 - $470,989
1,695 Added 5.62%
31,851 $9.36 Million
Q1 2022

Nov 14, 2022

SELL
$259.82 - $298.18 $1.86 Million - $2.13 Million
-7,146 Reduced 21.73%
25,745 $6.79 Million
Q1 2022

Sep 13, 2022

BUY
$259.82 - $298.18 $280,605 - $322,034
1,080 Added 3.71%
30,156 $7.95 Million
Q1 2022

May 09, 2022

SELL
$259.82 - $298.18 $174,858 - $200,675
-673 Reduced 2.26%
29,076 $8.87 Million
Q4 2021

Jan 27, 2022

BUY
$271.6 - $314.21 $1.19 Million - $1.37 Million
4,368 Added 17.21%
29,749 $9.35 Million
Q3 2021

Nov 12, 2021

SELL
$274.82 - $308.34 $106,904 - $119,944
-389 Reduced 1.51%
25,381 $7.14 Million
Q2 2021

Jul 29, 2021

SELL
$251.87 - $278.14 $115,356 - $127,388
-458 Reduced 1.75%
25,770 $7.11 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $14,546 - $18,107
-71 Reduced 0.27%
26,228 $6.69 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $61,867 - $70,973
331 Added 1.27%
26,299 $5.35 Million
Q3 2020

Nov 16, 2020

BUY
$167.03 - $201.3 $183,398 - $221,027
1,098 Added 4.41%
25,968 $4.89 Million
Q2 2020

Aug 14, 2020

SELL
$113.31 - $182.44 $11,331 - $18,244
-100 Reduced 0.4%
24,870 $4.13 Million
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $38,807 - $72,644
-372 Reduced 1.47%
24,970 $3.16 Million
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $36,129 - $38,367
-221 Reduced 0.86%
25,342 $4.29 Million
Q3 2019

Nov 14, 2019

BUY
$159.77 - $178.1 $86,275 - $96,174
540 Added 2.16%
25,563 $4.29 Million
Q2 2019

Aug 12, 2019

SELL
$144.16 - $172.9 $4.02 Million - $4.82 Million
-27,886 Reduced 52.71%
25,023 $4.33 Million
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $440,866 - $557,053
3,564 Added 7.22%
52,909 $8.09 Million
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $811,910 - $1.17 Million
6,720 Added 15.77%
49,345 $6.23 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $545,262 - $612,254
3,252 Added 8.26%
42,625 $7.4 Million
Q2 2018

Aug 10, 2018

BUY
$160.33 - $189.41 $1.61 Million - $1.9 Million
10,013 Added 34.1%
39,373 $7.07 Million
Q1 2018

Jun 28, 2018

BUY
$161.53 - $178.11 $2.47 Million - $2.73 Million
15,318 Added 109.09%
29,360 $4.75 Million
Q1 2018

May 14, 2018

SELL
$161.53 - $178.11 $2.74 Million - $3.03 Million
-16,987 Reduced 54.75%
14,042 $2.27 Million
Q4 2017

Feb 12, 2018

BUY
$147.99 - $163.95 $147,694 - $163,622
998 Added 3.32%
31,029 $4.95 Million
Q3 2017

Nov 13, 2017

SELL
$149.47 - $160.56 $9.91 Million - $10.6 Million
-66,325 Reduced 68.83%
30,031 $4.53 Million
Q2 2017

Aug 14, 2017

BUY
N/A
96,356
96,356 $14.9 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.